NIH SBIR/STTR Omnibus Solicitation

What this opportunity is, in plain English

This is NIH’s main small-business route for biomedical commercialization research and development funding through the SBIR and STTR programs. The opportunity page you are looking at is the official NIH starting point for both broad and targeted requests, with links to active notices and supporting pages.

The most practical way to think about this is: NIH provides non-dilutive funding opportunities for U.S. small businesses with ideas that can move toward products, diagnostics, devices, digital tools, or other health innovations. Some NIH awards are open under broad parent announcements (also called parent solicitations or parent NOFOs), and some are open under specific topic-focused RFAs/PASs.

NIH’s funding page currently states:

• NIH supports SBIR and STTR through NOFOs.
• No active funding opportunities may appear at any given time.
• Future NOFOs are published in advance on Grants.gov.
• The standard NIH submission dates remain September 5, January 5, and April 5.
• Dates on weekends or federal holidays move to the next business day.

This page is therefore both a funding page and a pipeline status page: when it says “no opportunities found,” your immediate action is usually preparation and watchful monitoring rather than panic.

At-a-glance details

Who this opportunity is for

This is for teams trying to convert an early-stage biomedical concept into a validated product-development pathway with federal support. You get the most value from this route if your team can answer:

• Do we have a technical problem with a likely user and market?
• Can we show early feasibility or strong rationale in one or two years?
• Do we need capital for experimental work, prototype development, or early clinical validation (depending on policy in the active NOFO)?

If yes, this can be one of the strongest “first real” innovation pipelines for startups and early small businesses.

You are likely a good match when you are:

• A for-profit U.S. small business willing to work inside NIH’s federal grant structure.
• Working on a health/biomedical use case where NIH mission alignment is clear.
• Building toward milestones that can be reviewed by third parties (scientific and commercial).

You are probably not a good match when:

• You need flexible spending with no reporting and no structured review.
• You are pre-prototype with only conceptual language and no measurable progress.
• Your business model depends on pure philanthropic funding and no commercialization milestones.

Why people use this route

Founders typically use this program because it is non-dilutive, science-friendly, and designed for companies that are too small or too early for traditional venture rounds. It is especially useful for:

• Validating technical performance and safety assumptions.
• Building the first rounds of clinical, preclinical, or translational evidence.
• Creating proof points for later private capital or strategic partnerships.

The NIH page notes non-dilutive support and places this within a larger commercialization ecosystem. That ecosystem includes technical and business support offerings, application resources, and portfolio follow-through for awardees.

Current status is not the same as long-term status

This opportunity page can be temporarily empty. At the time of verification, it reported no active NOFOs. That means there are no immediately open applications at that moment.

This is very common for federal calls. A useful way to interpret it:

• Not active now: no submission window to target this week.
• Not dead: NIH keeps the framework open and public.
• Not “cancelled”: openings are usually re-posted later through Grants.gov/NIH channels.

So if you are ready today, your first action is usually to line up your technical plan, registration stack, and review process for the next open cycle.

What you should understand before applying

The first decision is which track to use.

1) Parent solicitations (Omnibus)

These are broad, researcher-driven opportunities that are not restricted to one narrow topic line. NIH refers to these as the main path where many applications start. You still must map your topic to NIH’s stated areas and follow the applicable review rules, but you do not need to fit a highly narrow theme from day one.

2) Specific NOFOs (RFA/PAS)

Some NOFOs are narrow and topic-targeted. They may have set-aside budgets and more exact instructions. These are best when your idea is already tightly aligned to an announced NIH theme, institute priority, and evidence path.

Why this distinction matters

• Parent announcement route is good for broad researcher-driven opportunities.
• Specific NOFO route is useful when you have topic-level fit and want a focused evaluation panel.
• Using the wrong route can waste months.

Eligibility: what to check carefully

NIH SBIR/STTR programs are federal opportunities with strict eligibility and compliance requirements. The official page and related NIH pages direct you to SBA/NIH rules for definitive criteria, including business structure and ownership details.

In practical terms, verify these before you spend time drafting:

• SBA small-business status: You must be a qualifying U.S. small business concern.
• Ownership and affiliations: Complex ownership structures can reduce eligibility unexpectedly.
• SBIR vs STTR fit: STTR often requires stronger research-organization participation than SBIR.
• Performance benchmark constraints: NIH policy includes transition/commercialization benchmarks for firms with specific award histories.
• NIH NOFO-specific rules: PI and directorship conditions vary; review the actual NOFO text.

If your team is not sure on any of these, treat that as an early risk item and seek NIH staff input before application drafting.

How to decide if this is worth your time

Use a readiness scorecard:

• We can define a specific, reviewable problem statement.
• We can collect evidence for feasibility within the expected timeframe.
• We can keep records and milestones in a federally acceptable format.
• Core team can handle application compliance and submission checks.
• We can keep our timeline aligned with September/January/April cycles.

If at least four points are “yes,” you are likely worth continuing. If only one or two, your time is better spent on either hardening data, filing your registrations, or moving to a more immediate source of support.

End-to-end application process

This section is written for practical execution, not for legal language.

Step 1: Confirm active opportunities

Before drafting your application package, verify whether an active parent or specific NOFO is currently open.

• If active NOFO exists: identify exact NOFO number, title, and applicable institute.
• If none are active: do not force submission; go into prep mode.

Step 2: Prepare your business and compliance foundation

NIH and associated federal systems require core registrations:

• SAM (System for Award Management): required for U.S. federal business transactions.
• eRA Commons: required for NIH/HHS grant workflow and later updates.
• Grants.gov: required for official submission channel.
• SBA Company Registry: required for SBIR/STTR programs; you need an SBC control ID.

NIH and the SEED pages warn that registration can take weeks. Missing registrations are one of the most frequent and preventable blockers.

Step 3: Prepare a technically strong proposal in the correct system

When a NOFO is active:

1. Read required instructions in full before writing.
2. Build the required form package in the approved application system.
3. Validate form-level requirements early (system validations are stricter than a manual draft).
4. Prepare human-subjects/IRB content if relevant.
5. Ensure budget logic and compliance statements match NOFO instructions.
6. For STTR, confirm partner/institution collaboration expectations and agreements when applicable.

Step 4: Internal review

Do two independent reviews:

• A technical review for feasibility, logic, and risks.
• A compliance review for section placement, NIH instructions, and missing fields.

Don’t skip this step. NIH reviews are often lost on clarity, not just science.

Step 5: Submit and verify

• Submit through the prescribed channel.
• Confirm acknowledgment and status.
• Track status through NIH/Grants portal tools.
• Keep submission logs and receipts for internal records.

Step 6: After submission

Most applications do not fail only on science. Many fail because teams have weak response plans after submission questions or cannot answer follow-up details quickly. Keep a response owner and maintain versioned attachments and data.

At-a-glance readiness checklist

Use this before you commit final submission:

• Active NOFO number confirmed.
• Company and PI ownership structures reviewed against eligibility.
• All required registrations active before final signature windows.
• Correct route chosen (parent vs specific NOFO).
• Compliance section complete (human subjects, budgets, clinical trial status, data sharing if requested).
• SBA control ID and institutional partner setup documented.
• Final pre-submission review by at least one internal reviewer and one non-involved person.
• Submission confirmation received and archived.

What to include in a strong application (non-technical view)

Problem statement

State exactly what problem your technology solves, for whom, and why existing options are inadequate.

Approach

Describe what you will test, in sequence, and what will be considered success/failure at each stage.

Evidence plan

List current data, assumptions, and where evidence is missing.

Commercial path

Even early-stage proposals benefit from a realistic commercialization step:

• who would pay;
• what validation is required;
• what partners you need;
• what the next funding stage would be.

Team

Show the team’s ability to execute, not just their credentials. NIH reviewers often focus on whether the plan can actually be delivered.

Budget

Match each dollar to a task. Unlinked budget lines are easy to penalize.

Common mistakes to avoid

These are frequently seen in federal small-business submissions:

• Applying to the wrong mechanism.
• Waiting for registrations too late.
• Confusing NIH NOFO timing with calendar months and then missing the shifted deadline rule.
• Treating STTR collaboration as optional when a specific NOFO has stricter partnership expectations.
• Writing long scientific prose without a clear implementation path.
• Assuming “no active opportunities” means NIH is not funding this area at all.

The strongest prevention strategy is to plan backward from the due date and include compliance checkpoints every two weeks.

Timeline planning for the next cycle

When NIH opportunities are open, you can use this calendar model:

• Week 1-2: verify active NOFOs, register accounts, and assign owners.
• Week 3-4: build problem statement and first draft.
• Week 5-6: map budget and milestones, prepare compliance sections.
• Week 7-8: full technical and compliance internal review.
• Week 9-10: final edits, form validation, and pre-submit dry run.
• Week 11: submit at least one business day before the deadline if possible.

If your NOFO is in a specific topic line, compress this timeline and start earlier for that specific route.

What to do now if nothing is open

This can still be a productive period. Practical actions:

1. Clean corporate registration stack (SAM, eRA Commons, Grants.gov, SBA).
2. Create an NIH-ready project one-pager with clear milestones.
3. Prepare a data appendix so technical claims are auditable.
4. Reach out to NIH program staff for fit questions before your target cycle.
5. Track Grants.gov for the first forecast/NOFO appearance each cycle.

If you complete all five items, your first submission in the next open window will be far stronger than teams that start after the announcement.

Official links

• Main opportunity page: https://seed.nih.gov/small-business-funding/find-funding/sbir-sttr-funding-opportunities
• Grants.gov (NIH opportunities): https://www.grants.gov/
• How to apply at NIH: https://seed.nih.gov/small-business-funding/how-to-apply
• Required registrations: https://seed.nih.gov/small-business-funding/how-to-apply/before-you-apply/register-company
• Eligibility criteria: https://seed.nih.gov/small-business-funding/small-business-program-basics/eligibility-criteria
• Prepare your application (ASSIST and systems): https://seed.nih.gov/small-business-funding/how-to-apply/applying/prepare-your-application
• NIH grant policy references: https://seed.nih.gov/small-business-funding/small-business-program-basics/grant-policy
• NIH small-business funding considerations by ICO: https://grants.nih.gov/funding/funding-categories/small-business/ico-funding-considerations

FAQ

1) Is the NIH page down if it shows no current opportunities?

Not necessarily. It may simply mean no active NOFOs are open yet.

2) Can I start application work now?

Yes. Use closed periods to complete registrations and pre-build your package.

3) Do I need to apply every cycle?

No. Apply only when a suitable opportunity is open and aligned.

4) Are these funds enough for late-stage development?

Not by themselves. They are generally early development support designed to build de-risking milestones.

5) What is the biggest blocker in practice?

Readiness on registrations and route-selection errors.

6) Is this for all types of companies?

No. This is designed for qualifying U.S. small businesses under SBIR/STTR rules.

7) Where should I get help?

Use NIH SEED and contacts listed on the official pages.

8) Can I switch from SBIR to STTR later?

That is possible in some contexts, but route choice is NOFO-dependent and should be done before submission.

9) What if I miss one registration?

You may not be able to submit on time; in many cases this becomes a hard blocker.

10) What happens if my proposal is not selected?

You can reapply, but use review feedback and policy constraints as actionable guidance for the next cycle.

Keep moving after reading this page

If you are serious about NIH SBIR/STTR funding, the key move is simple:

• Confirm active call status.
• Confirm your route and eligibility.
• Prepare all registrations early.
• Build to reviewable milestones.
• Submit only when compliant and complete.

The opportunity is most valuable when your team uses NIH’s current pause periods for preparation instead of waiting for last-minute urgency.